Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and their organic compound interactions, and receptors on neurons, with the goal of developing new medication that may treat medical specialty disorders like pain, neurodegenerative diseases, and psychological disorders (also well-known during this case as neuropsychopharmacology). There are some technical words that have got to be outlined once relating neurotransmission to receptor action.

  • Agonist – a molecule that binds to a receptor super molecule and activates that receptor

  • Competitive antagonist – a molecule that binds to a similar website on the receptor super molecule because the agonist, preventing activation of the receptor

Non-competitive antagonist – a molecule that binds to a receptor supermolecule on a unique website than that of the agonist, however causes a conformational modification within the supermolecule that doesn't permit activation.


    Related Conference of Molecular Neuropharmacology

    April 27-28, 2023

    24th Global Nephrologists Meet

    Rome, Italy
    May 16-17, 2023

    13th International Conference on Nephrology and Kidney Diseases

    Singapore City, Singapore
    May 25-26, 2023

    19th World Nephrology Conference

    Singapore City, Singapore
    September 04-05, 2023

    8th World Kidney Congress

    Paris, France
    October 25-26, 2023

    11th World Congress on Epidemiology & Public Health

    Vancouver, Canada
    November 13-14, 2023

    27th European Nephrology Conference

    Barcelona, Spain
    November 20-21, 2023

    22nd Annual Conference on Urology and Nephrological Disorders

    Amsterdam, Netherlands

    Molecular Neuropharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in